Trial Number
270-22
Condition
Bacterial Infection
Participant Age Range
8 years to 18 years
Participant Gender
Any
Enrolling Participants
Yes
Overview
“A Phase 1, Open-Label, Multi-Center Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Single Intravenous and Oral Doses of Omadacycline in Pediatric Subjects with Suspected or Confirmed Bacterial Infections”
Study to Evaluate the PK of IV and PO Omadacycline in Children and Adolescents With Suspected or Confirmed Bacterial Infections.